文献速递中毒与环境急症重症综合管理与镇静镇痛

预测5-羟色胺再摄取抑制剂过量后的5-羟色胺毒性

Predicting serotonin toxicity in serotonin reuptake inhibitor overdose.
PubMed 文献 · Clin Toxicol (Phila) · 2022-11-29
一句话结论SSRI/SNRI过量后5-羟色胺毒性常见(13.6%),剂量影响小,合用奥氮平或利培酮风险降低2-6倍,合用吗氯贝胺风险增加5倍。

这项回顾性队列研究纳入23年间因SSRI(70%)或SNRI(30%)过量入住三级毒理学单元的1978次过量(1520例患者),采用多变量混合效应logistic回归模型分析5-羟色胺毒性的影响因素。5-羟色胺毒性发生率为13.6%。剂量每增加10个DDD单位风险略增(OR 1.01),SNRI较SSRI略增(OR 1.07),合用吗氯贝胺显著增加(OR 33.12)。风险随年龄每增加10岁降低(OR 0.84),合用奥氮平(OR 0.40)或利培酮(OR 0.13)降低。中位剂量15 DDD时,合用吗氯贝胺使概率升至83%,合用奥氮平或利培酮分别降至5.5%和1.8%。

要点

  • SSRI/SNRI过量后5-羟色胺毒性发生率为13.6%(269/1978次过量)。
  • 合用吗氯贝胺使5-羟色胺毒性风险显著增加(OR 33.12;95% CI 7.5-147),中位剂量15 DDD时概率升至83%。
  • 合用奥氮平(OR 0.40;95% CI 0.17-0.94)或利培酮(OR 0.13;95% CI 0.02-0.99)降低5-羟色胺毒性风险。
  • 剂量每增加10 DDD单位风险仅略增(OR 1.01;95% CI 0.93-1.10),年龄每增加10岁风险降低(OR 0.84;95% CI 0.74-0.95)。
  • SNRI较SSRI风险略增但未达统计学显著(OR 1.07;95% CI 0.99-1.15)。

适用人群与场景

  • 因SSRI(70%)或SNRI(30%)过量入住三级毒理学单元的患者,中位年龄33岁(范围13-86岁),64%为女性。
  • 85%(1678/1978)的过量存在合并摄入:5%(99例)合用奥氮平,3%(58例)合用利培酮,21%(417例)合用地西泮类药物,11例合用吗氯贝胺。

研究设计与关键结果

  • 研究类型:回顾性队列研究,纳入23年间因SSRI/SNRI过量入住三级毒理学单元的1978次过量(1520例患者),中位年龄33岁(范围13-86岁),64%女性,中位DDD为15(范围1-420)。
  • 5-羟色胺毒性发生于269次过量(13.6%)。
  • 剂量每增加10 DDD单位,5-羟色胺毒性概率略增(OR 1.01;95% CI 0.93-1.10);SNRI较SSRI略增(OR 1.07;95% CI 0.99-1.15),未达统计学显著。
  • 合用吗氯贝胺显著增加5-羟色胺毒性概率(OR 33.12;95% CI 7.5-147)。
  • 年龄每增加10岁,5-羟色胺毒性概率降低(OR 0.84;95% CI 0.74-0.95)。
  • 合用奥氮平(OR 0.40;95% CI 0.17-0.94)或利培酮(OR 0.13;95% CI 0.02-0.99)降低5-羟色胺毒性概率。
  • 5-羟色胺毒性概率在1 DDD(治疗量)时为12.5%,15 DDD时为12.7%,420 DDD时为19%。
  • 中位剂量15 DDD时,合用吗氯贝胺使概率升至83%,合用奥氮平或利培酮分别降至5.5%和1.8%。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,SSRI/SNRI过量后5-羟色胺毒性常见;尽管剂量增加概率,但效应小。
  • 作者认为,合用奥氮平或利培酮使风险降低2-6倍,合用吗氯贝胺使风险增加5倍。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: We aimed to investigate the frequency of serotonin toxicity following overdose of antidepressants that inhibit serotonin reuptake and the factors that influence the probability of serotonin toxicity occurring.

METHODS: This was a retrospective cohort study of overdoses that included selective serotonin reuptake inhibitors (SSRIs) (70%) and serotonin norepinephrine reuptake inhibitors (SNRIs) (30%) admitted to a tertiary toxicology unit over 23 years. A multivariate mixed effects logistic regression model using NONMEM (7.2.0) was used to determine factors that influenced the probability of serotonin toxicity occurring.

RESULTS: There were 1978 overdoses in 1520 patients; median age 33 y (range: 13-86 years) and 64% female. Median defined daily dose equivalent (DDD) was 15 (1-420). Co-ingestants were taken in 1678/1978 (85%) overdoses: 11 co-ingested the monoamine oxidase-A inhibitor (MAOI) moclobemide, 99 (5%) co-ingested olanzapine, 58 (3%) co-ingested risperidone and 417 co-ingested a benzodiazepine (21%). Serotonin toxicity occurred in 269 overdoses (13.6%). The probability of serotonin toxicity increased slightly per 10 DDD units dose [OR, 1.01; 95% confidence intervals (CIs): 0.93-1.10], increased for an SNRI vs. an SSRI [OR, 1.07; 95% CI: 0.99-1.15], and markedly increased with co-ingestion of moclobemide [OR, 33.12; 95% CI: 7.5-147]. The probability decreased per 10 y age [OR, 0.84; 95% CI: 0.74-0.95], and with co-ingestion of the serotonin 2 A receptor (5-HT2A) antagonists olanzapine [OR, 0.40; 95% CI: 0.17-0.94] or risperidone [OR, 0.13; 95% CI: 0.02-0.99]. The probability of serotonin toxicity was 12.5% at 1 DDD (therapeutic), 12.7% at 15 DDDs and 19% at 420 DDDs. In overdoses of the median dose of 15 DDDs, co-ingestion of moclobemide increased the probability to 83%, and co-ingestion of olanzapine or risperidone decreased it to 5.5% and 1.8%, respectively.

CONCLUSIONS: Serotonin toxicity is common following SSRI/SNRI overdose. Although dose increases probability, this was only a small effect. Co-ingestion with olanzapine or risperidone reduced the risk 2-6-fold, and moclobemide increased the risk 5-fold.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Cooper J, Duffull SB, Isbister GK, et al. Predicting serotonin toxicity in serotonin reuptake inhibitor overdose. Clin Toxicol (Phila). 2022. PMID: 36444913. doi:10.1080/15563650.2022.2151455

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。